Portola Pharmaceuticals, Inc. Shareholders' Equity
Portola Pharmaceuticals, Inc. had Shareholders' Equity of $129.82 million as of 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2020-02-28
- 2019-12-31: Stockholders' Equity Attributable to Parent $129.82M.
- 2019-09-30: Stockholders' Equity Attributable to Parent $212.89M.
- 2019-06-30: Stockholders' Equity Attributable to Parent $594.00K.
- 2019-03-31: Stockholders' Equity Attributable to Parent $48.42M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2019-12-31 | $129.82M 10-K · filed 2020-02-28 |
| 2019-09-30 | $212.89M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $594.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $48.42M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $88.40M 10-K · filed 2020-02-28 |
| 2018-09-30 | $164.42M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $217.68M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $307.99M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $346.87M 10-K · filed 2019-03-01 |
| 2017-09-30 | $426.04M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $111.02M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $161.62M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $190.53M 10-K · filed 2018-03-01 |
| 2016-09-30 | $236.52M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $320.99M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $370.61M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $427.40M 10-K · filed 2017-03-01 |
| 2015-09-30 | $322.91M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $368.03M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $418.98M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $347.80M 10-K · filed 2017-03-01 |
| 2014-09-30 | $209.23M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $241.90M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $269.19M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $296.33M 10-K · filed 2017-03-01 |
| 2013-09-30 | $197.95M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $214.60M 10-Q · filed 2013-08-14 |
| 2012-12-31 | -$191.57M 10-K · filed 2016-02-29 |
| 2011-12-31 | -$206.10M 10-K · filed 2015-03-02 |
| 2010-12-31 | -$228.41M 10-K · filed 2014-03-03 |